R Michael Carruthers, Chief Financial Officer at Fresh Tracks Therapeutics, holds ― shares in Fresh Tracks Therapeutics (Ticker: FRTX), holds 76.90K shares in Edgewise Therapeutics (Ticker: EWTX), holds ― shares in Elevation Oncology (Ticker: ELEV). Most recently, R Michael Carruthers ― shares of Fresh Tracks Therapeutics on ― for an estimated value of ―.
What is the percentage of profitable transactions made by R Michael Carruthers?
The percentage of profitable transactions made by R Michael Carruthers is 0%.
What is the average return per transaction made by R Michael Carruthers?
The average return per transaction made by R Michael Carruthers is -85.70%.
What stocks does R Michael Carruthers hold?
R Michael Carruthers holds: FRTX, EWTX, ELEV, OKUR stocks.
What was R Michael Carruthers’s latest transaction?
R Michael Carruthers latest transaction was an Uninformative Buy of ―.
What was R Michael Carruthers's most profitable transaction?
R Michael Carruthers’s most profitable transaction was an Informative Sell of EWTX stock on September 24, 2024. The return on the trade was -40.30%.
What is R Michael Carruthers's role in Fresh Tracks Therapeutics?
R Michael Carruthers's role in Fresh Tracks Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.